A detailed history of Crewe Advisors LLC transactions in Zimmer Biomet Holdings, Inc. stock. As of the latest transaction made, Crewe Advisors LLC holds 154 shares of ZBH stock, worth $16,973. This represents 0.0% of its overall portfolio holdings.

Number of Shares
154
Previous 234 34.19%
Holding current value
$16,973
Previous $25,000 36.0%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$104.47 - $116.17 $8,357 - $9,293
-80 Reduced 34.19%
154 $16,000
Q1 2024

May 13, 2024

BUY
$119.98 - $132.61 $28,075 - $31,030
234 New
234 $30,000
Q1 2023

May 12, 2023

SELL
$121.91 - $130.94 $2,925 - $3,142
-24 Reduced 10.71%
200 $25,000
Q4 2022

Feb 07, 2023

SELL
$104.7 - $128.4 $9,004 - $11,042
-86 Reduced 27.74%
224 $28,000
Q3 2022

Nov 14, 2022

BUY
$101.65 - $119.27 $3,557 - $4,174
35 Added 12.73%
310 $32,000
Q2 2022

Aug 02, 2022

BUY
$102.23 - $133.85 $7,667 - $10,038
75 Added 37.5%
275 $29,000
Q1 2022

Apr 27, 2022

BUY
$108.42 - $129.58 $8,673 - $10,366
80 Added 66.67%
200 $26,000
Q3 2021

Oct 29, 2021

SELL
$136.35 - $158.76 $10,635 - $12,383
-78 Reduced 39.39%
120 $18,000
Q3 2020

Oct 13, 2020

BUY
$113.59 - $141.68 $8,860 - $11,051
78 Added 65.0%
198 $27,000
Q1 2020

May 07, 2020

SELL
$78.28 - $155.73 $1,800 - $3,581
-23 Reduced 16.08%
120 $12,000
Q4 2019

Feb 05, 2020

BUY
$127.4 - $146.83 $2,930 - $3,377
23 Added 19.17%
143 $21,000
Q3 2018

Nov 13, 2018

SELL
$108.41 - $127.64 $13,009 - $15,316
-120 Reduced 50.0%
120 $16,000
Q2 2018

Aug 07, 2018

BUY
$102.12 - $114.04 $12,254 - $13,684
120 Added 100.0%
240 $26,000
Q4 2017

Feb 09, 2018

BUY
$105.55 - $120.83 $12,666 - $14,499
120
120 $14,000

Others Institutions Holding ZBH

About ZIMMER BIOMET HOLDINGS, INC.


  • Ticker ZBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 209,820,000
  • Market Cap $23.1B
  • Description
  • Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...
More about ZBH
Track This Portfolio

Track Crewe Advisors LLC Portfolio

Follow Crewe Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crewe Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crewe Advisors LLC with notifications on news.